The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma

Leukemia Research

Volumn 35, Issue 9, 2011, Pages 1269-1272

  Demirkesen, Cuyan ^a   Tüzüner, Nükhet ^a   Esen, Tuĝçe ^a   Lebe, Banu ^b   Özkal, Sermin ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

IgM; Immunohistochemistry; Large B cell lymphomas; Skin

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; PRIMARY CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA; PRIMARY CUTANEOUS FOLLICLE CENTER LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 80051469848     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.06.004     Document Type: Article

References (8)

1. Swerdlow S.H., Campo E., Haris N.L., et al. WHO Classification of Tumors Haematopoietic and Lymphoid Tissues 2008, WHO Press, Geneva, Switzerland.
2. Senff N.J., Hoefnagel J.J., Jansen P.M., et al. Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers. J Clin Oncol 2007, 25:1581-1587.
3. Kempf W., Sander C.A. Classification of cutaneous lymphomas-an update. Histopathology 2010, 56:57-70.
4. Grange F., Beylot-Barry M., Courville P., et al. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Arch Dermatol 2007, 143:1144-1150.
5. Senff N.J., Noordijk E.M., Kim Y.H., et al. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008, 112:1600-1609.
6. Robson A. Immunocytochemistry and the diagnosis of cutaneous lymphoma. Histopathology 2010, 56:71-90.
7. Koens L., Vermeer M.H., Willemze R., Jansen P.M. IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma. Am J Surg Pathol 2010, 34:1043-1048.
8. Kodama K., Massone C., Chott A., et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005, 106:2491-2497.